621 related articles for article (PubMed ID: 29288626)
1. The P2X7 receptor: A main player in inflammation.
Adinolfi E; Giuliani AL; De Marchi E; Pegoraro A; Orioli E; Di Virgilio F
Biochem Pharmacol; 2018 May; 151():234-244. PubMed ID: 29288626
[TBL] [Abstract][Full Text] [Related]
2. The P2X7 Receptor in Infection and Inflammation.
Di Virgilio F; Dal Ben D; Sarti AC; Giuliani AL; Falzoni S
Immunity; 2017 Jul; 47(1):15-31. PubMed ID: 28723547
[TBL] [Abstract][Full Text] [Related]
3. P2X7 Receptor as a Therapeutic Target.
De Marchi E; Orioli E; Dal Ben D; Adinolfi E
Adv Protein Chem Struct Biol; 2016; 104():39-79. PubMed ID: 27038372
[TBL] [Abstract][Full Text] [Related]
4. P2X7 receptor in multifaceted cellular signalling and its relevance as a potential therapeutic target in different diseases.
Mishra A; Behura A; Kumar A; Naik L; Swain A; Das M; Sarangi SS; Dokania P; Dirisala VR; Bhutia SK; Mishra A; Singh R; Dhiman R
Eur J Pharmacol; 2021 Sep; 906():174235. PubMed ID: 34097884
[TBL] [Abstract][Full Text] [Related]
5. P2X7 receptor and the NLRP3 inflammasome: Partners in crime.
Pelegrin P
Biochem Pharmacol; 2021 May; 187():114385. PubMed ID: 33359010
[TBL] [Abstract][Full Text] [Related]
6. P2X7 receptor antagonists: a patent review (2010-2015).
Park JH; Kim YC
Expert Opin Ther Pat; 2017 Mar; 27(3):257-267. PubMed ID: 27724045
[TBL] [Abstract][Full Text] [Related]
7. The role of P2X7 receptor in infectious inflammatory diseases and the influence of ectonucleotidases.
Morandini AC; Savio LE; Coutinho-Silva R
Biomed J; 2014; 37(4):169-77. PubMed ID: 25116711
[TBL] [Abstract][Full Text] [Related]
8. Structure-Activity Relationships and Therapeutic Potential of Purinergic P2X7 Receptor Antagonists.
El Idrissi IG; Podlewska S; Abate C; Bojarski AJ; Lacivita E; Leopoldo M
Curr Med Chem; 2024; 31(11):1361-1403. PubMed ID: 37013427
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the P2X7 purinergic receptor in inflammation: an update of antagonists series since 2009 and their promising therapeutic potential.
Baudelet D; Lipka E; Millet R; Ghinet A
Curr Med Chem; 2015; 22(6):713-29. PubMed ID: 25515510
[TBL] [Abstract][Full Text] [Related]
10. P2X7 receptors: channels, pores and more.
Volonté C; Apolloni S; Skaper SD; Burnstock G
CNS Neurol Disord Drug Targets; 2012 Sep; 11(6):705-21. PubMed ID: 22963440
[TBL] [Abstract][Full Text] [Related]
11. Structure, function and techniques of investigation of the P2X7 receptor (P2X7R) in mammalian cells.
Di Virgilio F; Jiang LH; Roger S; Falzoni S; Sarti AC; Vultaggio-Poma V; Chiozzi P; Adinolfi E
Methods Enzymol; 2019; 629():115-150. PubMed ID: 31727237
[TBL] [Abstract][Full Text] [Related]
12. Purinergic P2X7 Receptor: A Cation Channel Sensitive to Tumor Microenvironment.
Scarpellino G; Genova T; Munaron L
Recent Pat Anticancer Drug Discov; 2019; 14(1):32-38. PubMed ID: 30652649
[TBL] [Abstract][Full Text] [Related]
13. The evolution of P2X7 antagonists with a focus on CNS indications.
Rech JC; Bhattacharya A; Letavic MA; Savall BM
Bioorg Med Chem Lett; 2016 Aug; 26(16):3838-45. PubMed ID: 27426304
[TBL] [Abstract][Full Text] [Related]
14. Purinergic receptors: new targets for the treatment of gout and fibrosis.
Gicquel T; Le Daré B; Boichot E; Lagente V
Fundam Clin Pharmacol; 2017 Apr; 31(2):136-146. PubMed ID: 27885718
[TBL] [Abstract][Full Text] [Related]
15. P2X7 receptor blockade protects against cisplatin-induced nephrotoxicity in mice by decreasing the activities of inflammasome components, oxidative stress and caspase-3.
Zhang Y; Yuan F; Cao X; Zhai Z; GangHuang ; Du X; Wang Y; Zhang J; Huang Y; Zhao J; Hou W
Toxicol Appl Pharmacol; 2014 Nov; 281(1):1-10. PubMed ID: 25308879
[TBL] [Abstract][Full Text] [Related]
16. The potential of P2X7 receptors as a therapeutic target, including inflammation and tumour progression.
Burnstock G; Knight GE
Purinergic Signal; 2018 Mar; 14(1):1-18. PubMed ID: 29164451
[TBL] [Abstract][Full Text] [Related]
17. P2X7 receptors in the central nervous system.
Miras-Portugal MT; Ortega F; Gómez-Villafuertes R; Gualix J; Pérez-Sen R; Delicado EG
Biochem Pharmacol; 2021 May; 187():114472. PubMed ID: 33587917
[TBL] [Abstract][Full Text] [Related]
18. Recent Advances in the Development of Antidepressants Targeting the Purinergic P2X7 Receptor.
Lee S; Ha H; Jang J; Byun Y
Curr Med Chem; 2023; 30(2):164-177. PubMed ID: 35770396
[TBL] [Abstract][Full Text] [Related]
19. P2X7 Receptor Orchestrates Multiple Signalling Pathways Triggering Inflammation, Autophagy and Metabolic/Trophic Responses.
Orioli E; De Marchi E; Giuliani AL; Adinolfi E
Curr Med Chem; 2017; 24(21):2261-2275. PubMed ID: 28266268
[TBL] [Abstract][Full Text] [Related]
20. The role of microglia and P2X7 receptors in gliomas.
Kan LK; Williams D; Drummond K; O'Brien T; Monif M
J Neuroimmunol; 2019 Jul; 332():138-146. PubMed ID: 31031209
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
